Chang Jiang

Chang Jiang

Auto-generated profile, based on publicly available information

Chang Jiang

University of Pittsburgh

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2017 in Cell Host & Microbe
Verified
Journal Article
Closed access
YMYijie Ma
Yijie Ma
MWMichael J. Walsh
Michael J. Walsh
KBKatharina Bernhardt
Katharina Bernhardt
CACamille W. Ashbaugh
Camille W. Ashbaugh
STStephen J. Trudeau
Stephen J. Trudeau
BGBenjamin E. Gewurz
Benjamin E. Gewurz

1 May 2020 in Molecular Cell
Verified
Journal Article
Closed access
RGRui Guo
Rui Guo
CJChang Jiang
Chang Jiang
YZYuchen Zhang
Yuchen Zhang
AGApurva Govande
Apurva Govande
STStephen J. Trudeau
Stephen J. Trudeau
BGBenjamin Gewurz`
Benjamin Gewurz`

1 May 2017 in Cell Reports
Verified
Journal Article
Open access
IEIna Ersing
Ina Ersing
LNLuis Nobre
Luis Nobre
LWLiang Wei Wang
Liang Wei Wang
LSLior Soday
Lior Soday
YMYijie Ma
Yijie Ma
BGBenjamin Gewurz
Benjamin Gewurz
Epstein-Barr virus (EBV) replication contributes to multiple human diseases, including infectious mononucleosis, nasopharyngeal carcinoma, B cell lymphomas, and oral hairy leukoplakia. We performed systematic quantitative analyses of temporal changes in host and EBV proteins during lytic replication to gain insights into virus-host interactions, using conditional Burkitt lymphoma models of type I and II EBV infection. We quantified profiles of >8,000 cellular and 69 EBV proteins, including >500 plasma membrane proteins, providing temporal views of the lytic B cell proteome and EBV virome. Our approach revealed EBV-induced remodeling of cell cycle, innate and adaptive immune pathways, including upregulation of the complement cascade and proteasomal degradation of the B cell receptor complex, conserved between EBV types I and II. Cross-comparison with proteomic analyses of human cytomegalovirus infection and of a Kaposi-sarcoma-associated herpesvirus immunoevasin identified host factors targeted by multiple herpesviruses. Our results provide an important resource for studies of EBV replication.

18 May 2020 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
RGRui Guo
Rui Guo
YZYuchen Zhang
Yuchen Zhang
MTMingxiang Teng
Mingxiang Teng
CJChang Jiang
Chang Jiang
MSMolly Schineller
Molly Schineller
BGBenjamin Gewurz`
Benjamin Gewurz`

1 July 2019 in Cell Reports
Verified
Journal Article
Open access
CJChang Jiang
Chang Jiang
STStephen J. Trudeau
Stephen J. Trudeau
TCTaek-Chin Cheong
Taek-Chin Cheong
RGRui Guo
Rui Guo
MTMingxiang Teng
Mingxiang Teng
BGBenjamin Gewurz`
Benjamin Gewurz`
CD40 has major roles in B cell development, activation, and germinal center responses. CD40 hypoactivity causes immunodeficiency whereas its overexpression causes autoimmunity and lymphomagenesis. To systematically identify B cell autonomous CD40 regulators, we use CRISPR/Cas9 genome-scale screens in Daudi B cells stimulated by multimeric CD40 ligand. These highlight known CD40 pathway components and reveal multiple additional mechanisms regulating CD40. The nuclear ubiquitin ligase FBXO11 supports CD40 expression by targeting repressors CTBP1 and BCL6. FBXO11 knockout decreases primary B cell CD40 abundance and impairs class-switch recombination, suggesting that frequent lymphoma monoallelic FBXO11 mutations may balance BCL6 increase with CD40 loss. At the mRNA level, CELF1 controls exon splicing critical for CD40 activity, while the N6-adenosine methyltransferase WTAP negatively regulates CD40 mRNA abundance. At the protein level, ESCRT negatively regulates activated CD40 levels while the negative feedback phosphatase DUSP10 limits downstream MAPK responses. These results serve as a resource for future studies and highlight potential therapeutic targets.

23 October 2009 in Langmuir
Verified
Journal Article
Closed access
CGCaixin Guo
Caixin Guo
SLShaoqin Liu
Shaoqin Liu
CJChang Jiang
Chang Jiang
WLWenyuan Li
Wenyuan Li
ZDZhifei Dai
Zhifei Dai
XWXiaoyi Wu
Xiaoyi Wu